Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James S Hirsch

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Lancet. Diabetes & Endocrinology|November 27, 2022
FDA approves teplizumab: a milestone in type 1 diabetesJames S Hirsch
The Lancet. Diabetes & Endocrinology|August 29, 2022
Stigma in type 1 diabetes: a global problemJames S Hirsch
Journal of Diabetes Science and Technology|May 31, 2014
Patient Perspectives on Biosimilar InsulinAlasdair R Wilkins, Manu V Venkat, Adam S Brown, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Lancet. Diabetes & Endocrinology|November 27, 2022
FDA approves teplizumab: a milestone in type 1 diabetesJames S Hirsch
The Lancet. Diabetes & Endocrinology|August 29, 2022
Stigma in type 1 diabetes: a global problemJames S Hirsch
Journal of Diabetes Science and Technology|May 31, 2014
Patient Perspectives on Biosimilar InsulinAlasdair R Wilkins, Manu V Venkat, Adam S Brown, et al.
Pageof 1